Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Quebec, Commack NY, Berlin Corners VT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase2, Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

for
Mycosis Fungoides, Non-Hodgkin's Lymphoma
Location: Hackensack NJ, Pittsburgh PA, Iowa City IA, Dallas TX,
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT02848274

Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Boston MA, Garden City NY, New York NY, Lake Success NY,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Ottawa, North Miami FL, Aventura FL, Deerfield Beach FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05773274

Phase2, Recruiting

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

for
Advanced Non Small Cell Lung Cancer
Location: Iowa City IA
Sponsor: CellSight Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06107374

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: New York NY, Glen Burnie MD, Miami FL, Pittsburgh PA,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT05477576

Phase3, Recruiting

Pulmonary Hypertension Association Registry

for
Pulmonary Arterial Hypertension,
Location: Providence RI, Farmington CT, New York NY,
Sponsor: Pulmonary Hypertension Association, Inc.

Sex: All

Age: 0+

Code: NCT04071327

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Shirley NY, Mineola NY, The Bronx NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase3, Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

for
Lymphoma, T-Cell
Location: Boston MA, New York NY, Chapel Hill NC, Tampa FL,
Sponsor: March Biosciences Inc

Sex: All

Age: 18+

Code: NCT06534060

Phase2, Recruiting

New Non-invasive Modalities for Assessing Retinal Structure and Function

for
Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion,
Location: Iowa City IA
Sponsor: Randy Kardon

Sex: All

Age: 18 - 70+

Code: NCT03475173

Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

for
Hereditary Transthyretin-mediated (hATTR) Amyloidosis,
Location: Iowa City IA
Sponsor: Alnylam Pharmaceuticals

Sex: Female

Age: 0+

Code: NCT05040373

Recruiting

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

for
End-Stage Kidney Disease, End-Stage Renal Disease
Location: Gainesville FL, Decatur GA, Iowa City IA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05931276

Phase3, Recruiting

Prenatal Aspirin and Postpartum Vascular Function

for
Preeclampsia, Microvascular Function
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: Female

Age: 18 - 50

Code: NCT05653973

Early_phase1, Recruiting

Otoferlin Gene-mediated Hearing Loss Natural History Study

for
Sensorineural Hearing Loss, Bilateral
Location: Philadelphia PA, Cincinnati OH, Nashville TN,
Sponsor: Akouos, Inc.

Sex: All

Age: 0 - 44

Code: NCT05572073

Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for
Peripartum Cardiomyopathy, Postpartum
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Dennis M. McNamara, MD, MS

Sex: Female

Age: 18+

Code: NCT05180773

Recruiting

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Columbus OH, Indianapolis IN, Chicago IL, Madison WI,
Sponsor: Dwight Owen

Sex: All

Age: 18+

Code: NCT04919382

Phase2, Recruiting

Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children

for
Sex Trafficking, Sex Crimes, Commercial Sex, Sexual Violence,
Location: Des Moines IA
Sponsor: University of Michigan

Sex: All

Age: 13 - 21

Code: NCT06587529

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

for
Stroke, PFO - Patent Foramen Ovale
Location: Boston MA, New Haven CT, Allentown PA,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18 - 70

Code: NCT03821129

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

for
Congenital Myotonic Dystrophy
Location: Ottawa, Rochester NY, Pittsburgh PA, Chicago IL,
Sponsor: AMO Pharma Limited

Sex: All

Age: 6 - 45

Code: NCT05004129

Phase2, Phase3, Recruiting

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

for
Non-small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Mineola NY, Harrison NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06077760

Phase3, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa